Vision Sciences/Estech link up in atrial fibrillation:
This article was originally published in Clinica
Vision Sciences (Natick, Massachusetts) has signed a deal under which Estech (Danville, California) will distribute its cardiac surgery visualisation tools. Estech will market the minimally invasive CT-F100 and CTSS-F21 cardiothoracic endoscope and Slide-On EndoSheath system alongside its own products for ablation treatment of atrial fibrillation, a condition that affects 2 million people in the US and around 6 million worldwide.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.